Showing 5181-5190 of 5909 results for "".
- New Dates Announced for BMC Virtual Spring Symposiumhttps://modernod.com/news/new-dates-announced-for-bmc-virtual-spring-symposium/2477658/Bryn Mawr Communications (BMC) has announced that its first virtual educational initiative, the BMC Virtual Spring Symposium, will now be held on May 29-30. The BMC Virtual Spring Symposium is designed to enable discussion, engagement, and live Q&A for members of the vision community w
- Foundation Fighting Blindness To Jointly Host Online CME, COPE Webinarhttps://modernod.com/news/foundation-fighting-blindness-to-jointly-host-online-cme-cope-webinar/2477657/The Foundation Fighting Blindness has announced it will host its first continuing medical education (CME and COPE) event. The distance-learning course will be hosted on Monday, May 18, 2020 at 12 pm eastern time. The course will cover inherited retinal diseases (IRDs), Foundation resources, and c
- I-MED Pharma Gains Health Canada Approval For E>Eye Laserhttps://modernod.com/news/i-med-pharma-gains-health-canada-approval-for-eeye-laser/2477656/I-MED Pharma has announced Health Canada approval for dry eye device E>Eye Laser, which is now available to Canadian eye care professionals. E>Eye, designed and manufactured in France by E-Swin, is the only CE certified medical device using patented IRPL technology developed specifi
- Market Scope: COVID-19 Fallout Could Reshape Ophthalmology in Indiahttps://modernod.com/news/market-scope-covid-19-fallout-could-reshape-ophthalmology-in-india/2477647/Market Scope estimates the total ophthalmic market in India in 2020 at $1.3 billion, with an optimistic assumption that the COVID-19 suspension of elective surgeries will last for 2 months or less. The firms forecasts a rapid return to 2019 levels of activity, resulting in an overall 25 percent r
- COVID-19 Vaccine Protects Monkeys From New Coronavirus, Chinese Biotech Reportshttps://modernod.com/news/covid-19-vaccine-protects-monkeys-from-new-coronavirus-chinese-biotech-reports/2477646/For the first time, one of the many COVID-19 vaccines in development has protected an animal, rhesus macaques, from infection by the new coronavirus, according to a
- Ambulatory Surgery Centers Eligible For New Relief Grant Fundshttps://modernod.com/news/ambulatory-surgery-centers-eligible-for-new-relief-grant-funds-on-april-24/2477642/The Department of Health and Human Services (HHS) announced that, commencing April 24, health care providers, including ASCs, will be eligible to receive grants from a newly available pool of COVID-19 relief funds, according to The Outpatient Ophthalmic Surgery Society (OOSS). These grants are a
- Lancet Neurology Publishes Pivotal Phase 3 Data for Genentech’s Satralizumab for NMOSDhttps://modernod.com/news/lancet-neurology-publishes-pivotal-phase-3-data-for-genentechs-satralizumab-for-nmosd/2477640/Lancet Neurology published full pivotal phase 3 clinical data on investigational medicine satralizumab as a monotherapy for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating central nervous system disease that is commonly misdiagnosed as multiple scler
- Regenxbio Announces Additional Positive Long-Term and Interim Phase 1/2a Trial Update for RGX-314 for the Treatment of Wet AMDhttps://modernod.com/news/regenxbio-announces-additional-positive-long-term-and-interim-phase-1-2a-trial-update-for-rgx-314-for-the-treatment-of-wet-amd/2477630/Regenxbio provided additional long-term data from the ongoing phase 1/2a trial of RGX-314 for the treatment of wet age-related macular degeneration (AMD). In the phase 1/2a trial of RGX-314, 42 patients with severe wet AMD requiring frequent anti-vascular endothelial growth factor (anti-VE
- Novartis Acquires Amblyotech, A Provider of Digital Therapy for Treatment of Amblyopiahttps://modernod.com/news/novartis-acquires-amblyotech-a-provider-of-digital-therapy-for-treatment-of-amblyopia/2477623/Novartis announced that it has completed the acquisition of Amblyotech, a US-based software startup, and will, in collaboration with Ubisoft and McGill University, pursue the development of the acquired digital technology for the treatment of amblyopia. It is estimated that amblyopia affec
- NovaBay Pharmaceuticals Signs Agreement to Distribute COVID-19 Antibody Rapid Point-of-Care Test to US Health Care Professionalshttps://modernod.com/news/novabay-pharmaceuticals-signs-agreement-to-distribute-covid-19-antibody-rapid-point-of-care-test-to-u-s-healthcare-professionals/2477616/NovaBay Pharmaceuticals announced an agreement with Shenzhen Microprofit Biotech to become the exclusive US distributor of a rapid, finger prick test to determine the presence of COVID-19 or a potential indication of antibody immunity to COVID-19, according to a company news release. The fluoreca